Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell. 2003;114:323–34.
NOTES
Lamb, JustinRamaswamy, SridharFord, Heide LContreras, BernardoMartinez, Robert VKittrell, Frances SZahnow, Cynthia APatterson, NickGolub, Todd REwen, Mark EengCA88843/CA/NCI NIH HHS/F32-CA79197/CA/NCI NIH HHS/P01-CA80111/CA/NCI NIH HHS/R01-CA61253/CA/NCI NIH HHS/R01-CA65842/CA/NCI NIH HHS/Research Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.Cell. 2003 Aug 8;114(3):323-34. doi: 10.1016/s0092-8674(03)00570-1.
Abstract
Here we describe how patterns of gene expression in human tumors have been deconvoluted to reveal a mechanism of action for the cyclin D1 oncogene. Computational analysis of the expression patterns of thousands of genes across hundreds of tumor specimens suggested that a transcription factor, C/EBPbeta/Nf-Il6, participates in the consequences of cyclin D1 overexpression. Functional analyses confirmed the involvement of C/EBPbeta in the regulation of genes affected by cyclin D1 and established this protein as an indispensable effector of a potentially important facet of cyclin D1 biology. This work demonstrates that tumor gene expression databases can be used to study the function of a human oncogene in situ.
Last updated on 02/17/2021